An in vitro study of the dynamic features of the major histocompatibility complex class I complex relevant to its role as a versatile peptide-receptive molecule

Autor Hörig, Heidi, Papadopoulos, Nicholas J., Vegh, Zsuzsanna, Palmieri, Edith, Angeletti, Ruth H., Nathenson, Stanley G.
Vydáno 1997

T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell

Autor González, Pablo A., Carreño, Leandro J., Coombs, Daniel, Mora, Jorge E., Palmieri, Edith, Goldstein, Byron, Nathenson, Stanley G., Kalergis, Alexis M.
Vydáno 2005

Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy

Autor Lázár-Molnár, Eszter, Scandiuzzi, Lisa, Basu, Indranil, Quinn, Thomas, Sylvestre, Eliezer, Palmieri, Edith, Ramagopal, Udupi A., Nathenson, Stanley G., Guha, Chandan, Almo, Steven C.
Vydáno v EBioMedicine (2017)

Predominant occupation of the class I MHC molecule H-2K(wm7) with a single self-peptide suggests a mechanism for its diabetes-protective effect

Autor Brims, Daniel R., Qian, Jie, Jarchum, Irene, Mikesh, Leann, Palmieri, Edith, Ramagopal, Udupi A., Malashkevich, Vladimir N., Chaparro, Rodolfo J., Lund, Torben, Hattori, Masakazu, Shabanowitz, Jeffrey, Hunt, Donald F., Nathenson, Stanley G., Almo, Steven C., DiLorenzo, Teresa P.
Vydáno 2010